390 research outputs found
Towards the second H.E.S.S. Galactic plane catalogue
The H.E.S.S. Galactic Plane Survey (HGPS), carried out between 2004 and 2013,
is the most extensive survey of our Galaxy at very-high energies that covers
the southern sky. Since the first HPGS catalogue release, the new observations
accumulated provide a deeper scan of many Galactic sources, and a number of
improvements have been made at various stages of the data processing chain,
notably on events reconstruction and background modeling techniques. In
parallel a new catalog production workflow has been tested and optimized on
simulations done in preparation for the future Galactic Plane survey to be
conducted by the Cherenkov Telescope Array (CTA). The development of a common
data format and open scientific tools for gamma-ray astronomy allowed a smooth
transition from the exploratory work done on CTA simulations to its application
for H.E.S.S. data analysis. These elements offered a solid ground to build the
second H.E.S.S. Galactic Plane Survey catalogue (2HGPS). In the following we
will focus on the description of the catalogue workflow and show few results
along the way
Multiple emission components in the Cygnus cocoon detected from Fermi-LAT observations
Star-forming regions may play an important role in the life cycle of Galactic
cosmic rays. Gamma-ray observations of Cygnus X have revealed the presence of
an excess of hard-spectrum gamma-ray emission, possibly related to a cocoon of
freshly accelerated particles. Based on ~13 years of observations with the
Fermi-Large Area Telescope (LAT), we performed an improved
spectro-morphological characterisation of the residual emission including the
cocoon. The best-fit model for the cocoon includes two main emission
components: an extended component FCES G78.74+1.56, described by a 2D Gaussian
of extension r_{68} = 4.4^\circ \pm 0.1^\circ\,^{+0.1^\circ}_{-0.1^\circ},
and a central component FCES G80.00+0.50, traced by the distribution of ionised
gas within the borders of the photo-dissociation regions. The two have
significantly different spectra. An additional extended emission component FCES
G78.83+3.57, located on the edge of the central cavities in Cygnus X and with a
spectrum compatible with that of FCES G80.00+0.50, is likely related to the
cocoon. For the two main components, spectra and radial-azimuthal profiles of
the emission can be accounted for in a diffusion-loss framework involving one
single population of non-thermal particles. Particles span the full extent of
FCES G78.74+1.56 as a result of diffusion from a central source, and give rise
to source FCES G80.00+0.50 by interacting with ionised gas in the innermost
region. For this simple diffusion-loss model, viable setups can be very
different in terms of energetics, transport conditions, and timescales
involved, and both hadronic and leptonic scenarios are possible. The solutions
range from long-lasting particle acceleration, possibly in prominent star
clusters such as Cyg OB2 and NGC 6910, to a more recent and short-lived release
of particles within the last 10-100 kyr, likely from a supernova remnant.
(Abridged)Comment: Published in A&A. Fixed typos in metadata. The main results are
available in machine-readable format at
https://cdsarc.cds.unistra.fr/viz-bin/cat/J/A+A/671/A4
G313.3+00.3: A New Planetary Nebula discovered by the Australia Telescope Compact Array and the Spitzer Space Telescope
We present a new planetary nebula, first identified in images from the
Australia Telescope Compact Array, although not recognized at that time. Recent
observations with the Spitzer Space Telescope during the GLIMPSE Legacy program
have rediscovered the object. The high-resolution radio and infrared images
enable the identification of the central star or its wind, the recognition of
the radio emission as thermal, and the probable presence of polycylic aromatic
hydrocarbons in and around the source. These lead to the conclusion that
G313.3+00.3 is a planetary nebula. This object is of particular interest
because it was discovered solely through radio and mid-infrared imaging,
without any optical (or near-infrared) confirmation, and acts as a proof of
concept for the discovery of many more highly extinguished planetary nebulae.
G313.3+00.3 is well-resolved by both the instruments with which it was
identified, and suffers extreme reddening due to its location in the
Scutum-Crux spiral arm.Comment: 18 pages, LaTeX (aastex), incl. 8 PostScript (eps) figures and 1
table. Accepted by ApJ (Part 1
A Differential Drug Screen for Compounds That Select Against Antibiotic Resistance
Antibiotics increase the frequency of resistant bacteria by providing them a competitive advantage over sensitive strains. Here, we develop a versatile assay for differential chemical inhibition of competing microbial strains, and use it to identify compounds that preferentially inhibit tetracycline-resistant relative to sensitive bacteria, thus “inverting” selection for resistance. Our assay distinguishes compounds selecting directly against specific resistance mechanisms and compounds whose selection against resistance is based on their physiological interaction with tetracycline and is more general with respect to resistance mechanism. A pilot screen indicates that both types of selection-inverting compounds are secreted by soil microbes, suggesting that nature has evolved a repertoire of chemicals that counteracts antibiotic resistance. Finally, we show that our assay can more generally permit simple, direct screening for drugs based on their differential activity against different strains or targets
Measurement of the Bottom-Strange Meson Mixing Phase in the Full CDF Data Set
We report a measurement of the bottom-strange meson mixing phase \beta_s
using the time evolution of B0_s -> J/\psi (->\mu+\mu-) \phi (-> K+ K-) decays
in which the quark-flavor content of the bottom-strange meson is identified at
production. This measurement uses the full data set of proton-antiproton
collisions at sqrt(s)= 1.96 TeV collected by the Collider Detector experiment
at the Fermilab Tevatron, corresponding to 9.6 fb-1 of integrated luminosity.
We report confidence regions in the two-dimensional space of \beta_s and the
B0_s decay-width difference \Delta\Gamma_s, and measure \beta_s in [-\pi/2,
-1.51] U [-0.06, 0.30] U [1.26, \pi/2] at the 68% confidence level, in
agreement with the standard model expectation. Assuming the standard model
value of \beta_s, we also determine \Delta\Gamma_s = 0.068 +- 0.026 (stat) +-
0.009 (syst) ps-1 and the mean B0_s lifetime, \tau_s = 1.528 +- 0.019 (stat) +-
0.009 (syst) ps, which are consistent and competitive with determinations by
other experiments.Comment: 8 pages, 2 figures, Phys. Rev. Lett 109, 171802 (2012
Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma
<p>Abstract</p> <p>Background</p> <p>To elucidate relations of invasion of ulcerative colitis (UC)-associated carcinoma with its prognosis, the characteristics of invasive fronts were analyzed in comparison with sporadic colonic carcinomas.</p> <p>Methods</p> <p>Prognoses of 15 cases of UC-associated colonic carcinoma were compared with those of sporadic colon carcinoma cases, after which 75 cases of sporadic invasive adenocarcinoma were collected. Tumor budding was examined histologically at invasive fronts using immunohistochemistry (IHC) of pancytokeratin. Expressions of beta-catenin with mutation analysis, CD44 extracellular domain, Zo-1, occludin, matrix matalloproteinase-7, laminin-5γ2, and sialyl Lewis X (Le<sup>X</sup>) were immunohistochemically evaluated.</p> <p>Results</p> <p>UC-associated carcinoma showed worse prognosis than sporadic colon carcinoma in all the cases, and exhibited a tendency to become more poorly differentiated when carcinoma invaded the submucosa or deeper layers than sporadic carcinoma. When the lesions were compared with sporadic carcinomas considering differentiation grade, reduced expression of CD44 extracellular domain in UC-associated carcinoma was apparent. Laminin-5γ2 and sialyl-Le<sup>X </sup>expression showed a lower tendency in UC-associated carcinomas than in their sporadic counterparts. There were no differences in the numbers of tumor budding foci between the two lesion types, with no apparent relation to nuclear beta-catenin levels in IHC.</p> <p>Conclusions</p> <p>UC-associated carcinoma showed poorer differentiation when the carcinoma invaded submucosa or deeper parts, which may influence the poorer prognosis. The invasive behavior of UC-associated carcinoma is more associated with CD44 cleavage than with basement membrane disruption or sialyl-Lewis-antigen alteration.</p
3D extracellular matrix microenvironment in bioengineered tissue models of primary pediatric and adult brain tumors.
Dynamic alterations in the unique brain extracellular matrix (ECM) are involved in malignant brain tumors. Yet studies of brain ECM roles in tumor cell behavior have been difficult due to lack of access to the human brain. We present a tunable 3D bioengineered brain tissue platform by integrating microenvironmental cues of native brain-derived ECMs and live imaging to systematically evaluate patient-derived brain tumor responses. Using pediatric ependymoma and adult glioblastoma as examples, the 3D brain ECM-containing microenvironment with a balance of cell-cell and cell-matrix interactions supports distinctive phenotypes associated with tumor type-specific and ECM-dependent patterns in the tumor cells\u27 transcriptomic and release profiles. Label-free metabolic imaging of the composite model structure identifies metabolically distinct sub-populations within a tumor type and captures extracellular lipid-containing droplets with potential implications in drug response. The versatile bioengineered 3D tumor tissue system sets the stage for mechanistic studies deciphering microenvironmental role in brain tumor progression
PKA regulatory subunits mediate synergy among conserved G-protein-coupled receptor cascades
G-protein-coupled receptors sense extracellular chemical or physical stimuli and transmit these signals to distinct trimeric G-proteins. Activated Gα-proteins route signals to interconnected effector cascades, thus regulating thresholds, amplitudes and durations of signalling. Gαs- or Gαi-coupled receptor cascades are mechanistically conserved and mediate many sensory processes, including synaptic transmission, cell proliferation and chemotaxis. Here we show that a central, conserved component of Gαs-coupled receptor cascades, the regulatory subunit type-II (RII) of protein kinase A undergoes adenosine 3′-5′-cyclic monophosphate (cAMP)-dependent binding to Gαi. Stimulation of a mammalian Gαi-coupled receptor and concomitant cAMP-RII binding to Gαi, augments the sensitivity, amplitude and duration of Gαi:βγ activity and downstream mitogen-activated protein kinase signalling, independent of protein kinase A kinase activity. The mechanism is conserved in budding yeast, causing nutrient-dependent modulation of a pheromone response. These findings suggest a direct mechanism by which coincident activation of Gαs-coupled receptors controls the precision of adaptive responses of activated Gαi-coupled receptor cascades
Deregulation of Rab and Rab Effector Genes in Bladder Cancer
Growing evidence indicates that Rab GTPases, key regulators of intracellular transport in eukaryotic cells, play an important role in cancer. We analysed the deregulation at the transcriptional level of the genes encoding Rab proteins and Rab-interacting proteins in bladder cancer pathogenesis, distinguishing between the two main progression pathways so far identified in bladder cancer: the Ta pathway characterized by a high frequency of FGFR3 mutation and the carcinoma in situ pathway where no or infrequent FGFR3 mutations have been identified. A systematic literature search identified 61 genes encoding Rab proteins and 223 genes encoding Rab-interacting proteins. Transcriptomic data were obtained for normal urothelium samples and for two independent bladder cancer data sets corresponding to 152 and 75 tumors. Gene deregulation was analysed with the SAM (significant analysis of microarray) test or the binomial test. Overall, 30 genes were down-regulated, and 13 were up-regulated in the tumor samples. Five of these deregulated genes (LEPRE1, MICAL2, RAB23, STXBP1, SYTL1) were specifically deregulated in FGFR3-non-mutated muscle-invasive tumors. No gene encoding a Rab or Rab-interacting protein was found to be specifically deregulated in FGFR3-mutated tumors. Cluster analysis showed that the RAB27 gene cluster (comprising the genes encoding RAB27 and its interacting partners) was deregulated and that this deregulation was associated with both pathways of bladder cancer pathogenesis. Finally, we found that the expression of KIF20A and ZWINT was associated with that of proliferation markers and that the expression of MLPH, MYO5B, RAB11A, RAB11FIP1, RAB20 and SYTL2 was associated with that of urothelial cell differentiation markers. This systematic analysis of Rab and Rab effector gene deregulation in bladder cancer, taking relevant tumor subgroups into account, provides insight into the possible roles of Rab proteins and their effectors in bladder cancer pathogenesis. This approach is applicable to other group of genes and types of cancer
- …